©2024 Stanford Medicine
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Not Recruiting
Trial ID: NCT05201781
Purpose
The purpose of this study is to collect long-term follow-up data on delayed adverse events
after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and
understand the long-term safety profile of cilta-cel.
Official Title
Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Stanford Investigator(s)
Surbhi Sidana, MD
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Eligibility
Inclusion Criteria:
- Participants who have received at least one dose of cilta-cel in a Company-sponsored
clinical study
- Participants who have provided informed consent for this study
Intervention(s):
drug: Cilta-cel
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Kelly Chyan
650-625-8130